[HTML][HTML] The role of cystine/glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer
N Jyotsana, KT Ta, KE DelGiorno - Frontiers in oncology, 2022 - frontiersin.org
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
N Jyotsana, KT Ta, KE DelGiorno - Frontiers in Oncology, 2022 - cir.nii.ac.jp
抄録< jats: p> SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine
in exchange for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor …
in exchange for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor …
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
N Jyotsana, KT Ta, KE DelGiorno - Frontiers in oncology, 2022 - pubmed.ncbi.nlm.nih.gov
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer. Front
N Jyotsana, KT Ta, KE DelGiorno - Women in Gastrointestinal …, 2022 - books.google.com
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
[HTML][HTML] The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
N Jyotsana, KT Ta, KE DelGiorno - Frontiers in Oncology, 2022 - ncbi.nlm.nih.gov
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
[HTML][HTML] The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer
N Jyotsana, KT Ta, KE DelGiorno - Frontiers in Oncology, 2022 - frontiersin.org
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
N Jyotsana, KT Ta, KE DelGiorno - Frontiers in Oncology, 2022 - europepmc.org
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
N Jyotsana, KT Ta, KE DelGiorno - Frontiers in Oncology, 2022 - europepmc.org
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …